Non-guideline-endorsed posttreatment courses of antibiotics for post–Lyme disease syndrome (PLDS) have been linked to adverse patient outcomes, but these findings have yet to be validated in large systematic evaluations.

中文翻译：

---

商业保险样本中与抗生素和静脉治疗莱姆病后综合征相关的不良事件

莱姆病后综合征（PLDS）的未经指南认可的抗生素治疗后疗程与不良患者预后相关，但这些发现尚待大型系统评估验证。